Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial.

Saved in:
Bibliographic Details
Title: Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-difference trial.
Authors: Landmesser U; Deutsches Herzzentrum der Charité, Klinik für Kardiologie, Angiologie und Intensivmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117 Berlin, Germany., Laufs U; Department of Cardiology, Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany., Schatz U; Department of Internal Medicine III, Faculty of Medicine at the Technical University of Dresden, University Hospital Carl Gustav Carus, Dresden, Germany., Winzer EB; Department for Internal Medicine and Cardiology, Heart Center Dresden, University Clinic, Technische Universität Dresden, Dresden, Germany., Nowak B; CCB, Cardioangiologisches Centrum Bethanien, Frankfurt a.M., Germany., Kassner U; Division of Lipid Disorders, Department of Endocrinology, Charité-Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Gouni-Berthold I; Center for Endocrinology, Diabetes and Preventive Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Esteban A; Clinical Development, Novartis Pharma AG, Basel, Switzerland., Lubyayi L; Advanced Quantitative Sciences, Novartis Pharmaceuticals UK Ltd, London, UK., Krueger A; Global Medical Affairs, Cardio Renal Metabolism, Novartis Pharma AG, Basel, Switzerland., Hentschke C; Evidence Generation, Novartis Pharma GmbH, Nürnberg, Bayern, Germany., Wilke A; Kardiologische Praxis Papenburg, Papenburg, Germany., Winkelmann BR; Study Center, ClinPhenomics CVC GmbH, Frankfurt, Germany., Achouba A; Global Medical Affairs, ASCVD, Novartis Pharma AG, Basel, Switzerland., Banach M; Faculty of Medicine, the John Paul II Catholic University of Lublin, Lublin, Poland.; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Preventive Cardiology and Lipidology, Medical University of Lodz, Lodz, Poland.
Source: European heart journal [Eur Heart J] 2026 Jul 01; Vol. 47 (25), pp. 3241-3253.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1522-9645
DOI:10.1093/eurheartj/ehaf685